药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Fimasartan
The excretion of Fimasartan can be decreased when combined with Lopinavir.
Metacycline
Gadoxetic acid
The excretion of Gadoxetic acid can be decreased when combined with Lopinavir.
Metacycline
Cholecystokinin
The excretion of Cholecystokinin can be decreased when combined with Lopinavir.
Metacycline
Temocapril
The excretion of Temocapril can be decreased when combined with Lopinavir.
Metacycline
Gimatecan
The excretion of Gimatecan can be decreased when combined with Lopinavir.
Metacycline
Atrasentan
The excretion of Atrasentan can be decreased when combined with Lopinavir.
Metacycline
Inotersen
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Inotersen.
Metacycline
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Pipemidic acid.
Metacycline
Rufloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Rufloxacin.
Metacycline
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Lidoflazine.
Metacycline
Piromidic acid
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Piromidic acid.
Metacycline
Lorajmine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Lorajmine.
Metacycline
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Oxolinic acid.
Metacycline
Prajmaline
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Prajmaline.
Metacycline
Bencyclane
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Bencyclane.
Metacycline
Cibenzoline
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Cibenzoline.
Metacycline
Gallopamil
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Gallopamil.
Metacycline
Cicletanine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Cicletanine.
Metacycline
Pilsicainide
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Pilsicainide.
Metacycline
Givinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Givinostat.